BIOTECH INNOVATION ApS
CVR number: 31171997
Skippergade 10, 9340 Asaa
gmp@biotech-i.dk
tel: 21567150
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 460.77 | 1 812.52 | 1 285.47 | 640.07 | 881.96 |
| Employee benefit expenses | -1 452.79 | -1 516.20 | -1 509.50 | -1 460.83 | -1 300.49 |
| Total depreciation | -30.90 | -30.49 | -11.50 | -27.15 | -5.55 |
| EBIT | 977.07 | 265.83 | - 235.53 | - 847.91 | - 424.09 |
| Other financial income | 4.17 | ||||
| Other financial expenses | -74.22 | -77.40 | -80.13 | -86.34 | -86.69 |
| Pre-tax profit | 902.85 | 188.44 | - 315.66 | - 934.26 | - 506.61 |
| Income taxes | - 199.75 | -41.97 | 68.94 | 62.86 | 47.71 |
| Net earnings | 703.11 | 146.46 | - 246.72 | - 871.40 | - 458.89 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 17.92 | 13.19 | 10.45 | 10.00 | 10.00 |
| Tangible assets total | 17.92 | 13.19 | 10.45 | 10.00 | 10.00 |
| Investments total | |||||
| Non-current other receivables | 39.11 | 39.11 | 39.11 | 54.11 | 15.00 |
| Long term receivables total | 39.11 | 39.11 | 39.11 | 54.11 | 15.00 |
| Raw materials and consumables | 695.67 | 674.19 | 586.53 | 579.46 | 485.92 |
| Inventories total | 695.67 | 674.19 | 586.53 | 579.46 | 485.92 |
| Current trade debtors | 3.12 | 210.71 | 263.39 | 13.63 | 34.23 |
| Current amounts owed by group member comp. | 32.00 | 94.13 | |||
| Prepayments and accrued income | 100.03 | 83.37 | 89.44 | 76.64 | 14.03 |
| Current other receivables | 349.88 | 48.76 | |||
| Current deferred tax assets | 3.20 | 1.50 | 70.44 | 64.96 | 47.71 |
| Short term receivables total | 106.34 | 645.46 | 472.03 | 187.23 | 190.11 |
| Cash and bank deposits | 1 084.55 | 1 074.73 | 822.46 | 204.11 | 4.53 |
| Cash and cash equivalents | 1 084.55 | 1 074.73 | 822.46 | 204.11 | 4.53 |
| Balance sheet total (assets) | 1 943.59 | 2 446.67 | 1 930.58 | 1 034.91 | 705.56 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 208.00 | 208.00 | 208.00 | 208.00 | 208.00 |
| Retained earnings | -1 288.16 | - 585.06 | - 438.59 | - 685.31 | -1 556.71 |
| Profit of the financial year | 703.11 | 146.46 | - 246.72 | - 871.40 | - 458.89 |
| Shareholders equity total | - 377.06 | - 230.59 | - 477.31 | -1 348.71 | -1 807.61 |
| Non-current other liabilities | 50.92 | ||||
| Non-current liabilities total | 50.92 | ||||
| Current trade creditors | 127.99 | 96.93 | 97.56 | 80.31 | 29.89 |
| Current owed to participating | 82.00 | ||||
| Current owed to group member | 1 562.18 | 1 822.40 | 2 054.08 | 2 148.48 | 2 192.85 |
| Short-term deferred tax liabilities | 174.33 | 40.27 | |||
| Other non-interest bearing current liabilities | 456.14 | 666.74 | 256.26 | 154.84 | 208.43 |
| Current liabilities total | 2 320.65 | 2 626.34 | 2 407.89 | 2 383.63 | 2 513.17 |
| Balance sheet total (liabilities) | 1 943.59 | 2 446.67 | 1 930.58 | 1 034.91 | 705.56 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.